艾昆纬（IQVIA）：2025年全球药品使用报告：展望至2029年（英文版）（59页）.pdf

1、Copyright 2025 IQVIA.All rights reserved.IQVIA is a registered trademark of IQVIA Inc.in the United States and various other countries.The Global Use of Medicines 2025:Outlook to 2029Global WebinarA u g u s t 2 7,2 0 2 52Todays panelistsHoward ChenHead of Services,MC&PI,ChinaAlan ThomasSenior Direct

2、or,Thought Leadership,JapanSarah RickwoodVP,Thought Leadership,EMEALuke Greenwalt VP,Thought Leadership and Innovation,U.S.Sydney ClarkVP,Consulting Services,Latin AmericaMark Omoto GM,Thought Leadership and Marketing,CanadaModerator:Murray AitkenExecutive Director,IQVIA InstituteResearch Highlights

3、:Michael KleinrockResearch Director,IQVIA InstituteResearch Highlights4 3Growth outlook continues to increaseGlobal medicines market:outlook to 2029Outlook for U.S.market is higherMedicine use rising in LATAM and AsiaGrowth outlook unchanged at 5-8%CAGR,reaching$2.4Tn by 2029,driven by immunology an

4、d oncology despite both slowing later in the forecast,and endocrinology,especially diabetes and obesityMedicine use in Latin America and Asia,including China,will grow faster than other regions over the next five yearsThe updated outlook for the U.S.market,using estimated net prices,is being raised

5、by 1 percentage points to 3-6%CAGR through 2029,reflecting higher recent growth and expected further increased patient use of higher value therapies Medicine use overall continues to increaseGlobal use of medicines grew by 14%over the past five years but an increase of only 4%is expected through 202

6、9,bringing annual use to 3.7 trillion defined daily doses and reflecting slowing growth across developed and developing economies.Global spending is increasingGlobal spending on medicine using list prices grew by 38%over the past five years and is forecast to increase by 35%through 20295156201254394